Lovastatin
- TRADE NAMES: Advicor (Kos); Altocor; Altoprev (Shionogi); Apo-Lovastatin; Lovalip; Mevacor (Merck); Mevinacor; Mevinolin; Nergadan; Rovacor; Taucor
- INDICATIONS: Hypercholesterolemia
- CLASS: HMG-CoA reductase inhibitor / statin
- HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Atazanavir, Azithromycin, Boceprevir, Bosentan, Cholestyramine, Clarithromycin, Cyclosporine, Darunavir, Delavirdine, Efavirenz, Elbasvir & Grazoprevir, Erythromycin, Exenatide, Fenofibrate, Fosamprenavir, Gemfibrozil, Glecaprevir & Pibrentasvir, Grapefruit Juice, Imatinib, Indinavir, Itraconazole, Letermovir, Lomitapide, Lonafarnib, Lopinavir, Mifepristone, Nelfinavir, Ombitasvir/Paritaprevir/Ritonavir, Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, Paclitaxel, Posaconazole, Red Rice Yeast, Tacrolimus, Telaprevir, Telithromycin, Ticagrelor, Tipranavir, Tolvaptan, Verapamil, Viloxazine
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric